East Asia & Pacific (IDA & IBRD countries) vs Switzerland: Treatment for hypertension

East Asia & Pacific (IDA & IBRD countries)
35.5%
in 2019
Switzerland
56.1%
in 2019
East Asia & Pacific (IDA & IBRD countries) rank
29th
Switzerland rank
30th

Treatment for hypertension over time

  • East Asia & Pacific (IDA & IBRD countries)
  • Switzerland
102030405060199020042019

How they compare

Switzerland currently reports 56.1% against 35.5% in East Asia & Pacific (IDA & IBRD countries), a difference of 20.6%.

That makes Switzerland's figure about 1.6 times East Asia & Pacific (IDA & IBRD countries)'s.

Across all 30 years both countries report, Switzerland has been ahead every year.

East Asia & Pacific (IDA & IBRD countries) ranks 29th and Switzerland ranks 30th of 43 groups.

Switzerland has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade East Asia & Pacific (IDA & IBRD countries) Switzerland Difference Ahead
1990s 15.9% 30.2% 14.3% Switzerland
2000s 27.1% 43.9% 16.8% Switzerland
2010s 34.7% 53.8% 19.1% Switzerland

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment for hypertension, East Asia & Pacific (IDA & IBRD countries) or Switzerland?
Switzerland, at 56.1% against 35.5% in East Asia & Pacific (IDA & IBRD countries) as of 2019.
What is the difference in treatment for hypertension between East Asia & Pacific (IDA & IBRD countries) and Switzerland?
20.6%, with Switzerland ahead.
How many years of comparable data are there for East Asia & Pacific (IDA & IBRD countries) and Switzerland?
30 years are reported by both, from 1990 to 2019.
How do East Asia & Pacific (IDA & IBRD countries) and Switzerland rank globally for treatment for hypertension?
East Asia & Pacific (IDA & IBRD countries) ranks 29th and Switzerland ranks 30th of 43 groups.
Where does this data come from?
World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension (% of adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

East Asia & Pacific (IDA & IBRD countries) vs Switzerland: Treatment for hypertension. Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 19 September 2026, from https://health.statizoid.com/compare/treatment-for-hypertension-percent-of-adults-ages-30-79-with-hypertension/east-asia-and-pacific-ida-and-ibrd-countries/switzerland/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-for-hypertension-percent-of-adults-ages-30-79-with-hypertension/east-asia-and-pacific-ida-and-ibrd-countries/switzerland/">East Asia & Pacific (IDA & IBRD countries) vs Switzerland: Treatment for hypertension</a> — Statizoid

About this data

Indicator
Treatment for hypertension (% of adults ages 30-79 with hypertension)
Unit
% of adults ages 30-79 with hypertension
Source
World Health Organization's Global Health Observatory Data Repository
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 7,050 data points, 1990–2019
Last refreshed

Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.